Drug recall · June 3, 2026
Nicotine Transdermal System Patch recall
Why: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
- Lots / codes
Lot #: 56841, Expires: 03/2028
- Quantity
- 59,808 pouches (4,272 Individual Folding Carton (IFC))
- Company
- AVEVA Drug Delivery Systems, Inc., Miramar, FL
- Distribution
- Nationwide within the U.S
- Initiated
- May 14, 2026 · Voluntary: Firm initiated
- Classified
- May 26, 2026
- Reported
- June 3, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nicotine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.